MeiraGTx Holdings plc (MGTX)
NASDAQ: MGTX · Real-Time Price · USD
13.76
-0.01 (-0.11%)
Aug 18, 2026, 3:03 PM EDT - Market open
MeiraGTx Holdings Market Cap
MeiraGTx Holdings has a market cap or net worth of $1.32 billion as of August 18, 2026. Its market cap has increased by 100.98% in one year.
Market Cap
1.32B
Enterprise Value
1.29B
1-Year Change
100.98%
Ranking
Category
Stock Price
$13.76
ChartMarket Cap Chart
Since June 8, 2018, MeiraGTx Holdings's market cap has increased from $407.80M to $1.32B, an increase of 223.95%. That is a compound annual growth rate of 15.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 1.32B | 106.45% |
| Dec 31, 2025 | 639.90M | 34.43% |
| Dec 31, 2024 | 476.00M | 6.61% |
| Dec 29, 2023 | 446.50M | 53.12% |
| Dec 30, 2022 | 291.60M | -72.37% |
| Dec 31, 2021 | 1.06B | 81.43% |
| Dec 31, 2020 | 581.60M | -20.57% |
| Dec 31, 2019 | 732.20M | 177.35% |
| Dec 31, 2018 | 264.00M | -35.26% |
| Jun 8, 2018 | 407.80M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aktis Oncology | 1.37B |
| Savara | 1.36B |
| Vor Biopharma | 1.36B |
| Inhibrx Biosciences | 1.35B |
| Novavax | 1.33B |
| Cullinan Therapeutics | 1.33B |
| Alto Neuroscience | 1.32B |
| Monte Rosa Therapeutics | 1.31B |